Complications of PCI by Dr Sh.Golmohammadzadeh Interventional cardiologist.

Slides:



Advertisements
Similar presentations
INTERVENTIONAL CARDIOLOGY AN OVERVIEW
Advertisements

Prevention of Contrast-Induced Nephropathy (CIN) Sepehr Khashaei, MD Assistant professor Department of Internal Medicine.
Assisted Circulation MEDICAL MEDICAL  Drugs  EECP MECHANICAL  IABP ( Introaortic balloon pump)  VAD (Ventricular assist device)
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Advanced Treatment Options for Stroke Patients Vickie Gordon PhD, ACNP-BC, CNRN.
Intra-aortic Balloon Pump (IABP)
BBC ONE David Hildick-Smith Sussex Cardiac Centre Brighton, UK on behalf of the BBC ONE Investigators.
Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
AVE Micro Stent KFSH & RC Experience with 6 months Angiographic Follow Up Layth A. Mimish, M. Bakhshi, F. Al-Nozha, A. Kinsara, O. Amoudi, J. Buraiki,
Cardiogenic Shock and Hemodynamics. Outline Overview of shock – Hemodynamic Parameters – PA catheter, complications – Differentiating Types of Shock Cardiogenic.
Complications of HSRA Layth A. Mimish Consultant Cardiologist Cardiovascular Consultants Group Jeddah, Saudi Arabia.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Ischemic heart disease
Screening for Contrast and Reactions Barnes-Jewish Hospital Monica White MBA, RT, R.
HEAPHY 1 & 2 CASE RACE 1 – DIAG Rowena OLIVER Sat 31 st Aug 2013 Session 3 / CR1-6 13:26 – 13:30 OTAGO / SOUTHLAND ABSTRACT A case of a 81 year old female.
Raising the standard in treating bifurcation lesions GENNARO SARDELLA MD, FACC,FESC O.U. of Interventional Cardiology Dept. of.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
WG Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
PCI Percutaneous Coronary Intervention prepared by: Sue Feltham RN, ACNP revised by: Amanda Darwood RN, BSc.
Indication and contra-indications for cardiac catheterization
Presentation: Presented with progressive dyspnea on exertion and cresendo angina CCS Class III, presented on 10/14/2011 and cath revealed mild pulm HTn,
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Chapter 16 Assessment of Hemodynamic Pressures
Nursing and heart failure
Richard Melsheimer Director, Medical Affairs Europe Centocor Eli Lilly and Company Coordinated Use of ReoPro and Drug Eluting Stents: Rationale and Evidence.
Cardiogenic Shock Dr. Belal Hijji, RN, PhD October 12 & 15, 2011.
Diagnosis and Management of Shock Dr. Anas Khan Consultant, EM MBBS, MHA, ArBEM.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
ΕΚΕ Hellenic PCI Registry ( ) Περιεχόμενο και αναγκαιότητα διατήρησης Registry Αγγειοπλαστικής Georgios.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
Pre-ICU training. 工作態度 會客時主動告知病情 病歷每天書寫 2 次 主動反應問題 接觸病人前後洗手.
Dr. Sohail Bashir Sulehria
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Case 60 F with PMH HTN, DM, CVA presented to UNC ED CC: seizure. Per the daughter the pt was walking and all of a sudden fell and her whole body started.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
1 Shock. 2 Shock refers to an abnormality of the circulatory system in which there is inadequate tissue perfusion due to a relatively or absolutely inadequate.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
Multivessel Coronary Artery Disease
Issued in 2014 – SCAAR. SCAAR Annual report 2013.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Afsane mohammadi,MD Interventional cardiologist.  The presence of inducible ischemia is an important risk factor for adverse outcome.the more inducible.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Drugs for Angina Pectoris
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Cardiac Catheterization Complication
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Costs of Periprocedural Complications in Patients Treated with Transcatheter Aortic Valve Replacement: Results from The PARTNER Trial Suzanne V. Arnold,
Layth A. Mimish, M. Bakhshi, J. Buraiki,
The Radial Approach for CTO PCI Utility in the Retrograde and the Antegrade Approaches Shigeru Saito, MD, FACC, FSCAI, FJCC Shonan Kamakura General Hospital.
Management of ST-Elevation Myocardial Infarction
Procedural factors associated with PCI-related ischemic stroke
Women, Bleeding, and Coronary Intervention
Subintimal Tracking and Reentry for CTO STAR Method
ACUTE ARTERIAL OCCLUSION (Acute Limb Ischemia )
Cardiac Cath NUR 422.
Cath Lab Catastrophes : Prevention & Management Strategies
Myocardial Staining (TMPG 1)  Post-Stent in AMI
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Presentation transcript:

Complications of PCI by Dr Sh.Golmohammadzadeh Interventional cardiologist

Classification General classification ( AHA ): 1- Contrast nephropathy 2- Vascular 3-CVA 4- Emergency CABG 5-MI 6- Death

Practical & Detailed Classification Medical complications : - Atheroembolism - Neurologic - Infection - Contrast related reactions & complications - Hematologic complications Peripheral Vascular complications Coronary complications

Causes of Renal Insufficiency in PTCA patient PRE-RENAL CAUSES : 1) Volume depletion :NPO status, Contrast - induced diuresis,Blood loss. 2)Diminished cardiac output :Contrast-induced myocardial depression,Myocardial ischemia RENAL CAUSES: Contrast-induced Renal ischemia,Atheroembolism PERI-RENAL CAUSES: Aortic dissection, malaposition of LABP,drugs POST –RENAL CAUSES

Renal Insufficiency -2 Prevention : 1- IV fluids 2- Non-Ionic Contrasts 3- Avoid nephrotoxic drugs ( NSAIDs ) 4- Avoid loop diuretics 5- Dopamine 6- Theophylline 7- N-Acetylcysteine 8- Fenoldopam

Renal Insufficiency -3 Risk factors for CM induced nephropathy : - baseline Cr > 1.5 mg% or Ccr<60 cc/min - diabetic nephropathy - heart failure ( FC III-IV ) - large volume of CM **( 5ml per kg / Cr ) - prior CM induced nephropathy - intravascular volume depletion * hypertension,* advanced age,* proteinuria

Contrast Reactions -1 Hemodynamic effects Electrophysiological effects Minor reactions ( urticaria, nausea,…. ) Moderate reactions (angioedema,laryngeal edema, bronchospasm ) Severe reactions (anaphylaxis, hypotension) Thrombosis Nephrotoxicity

Contrast Reactions -2 Pre – medication for prevention of reactions - Prednisone - Diphenhydramine - H 2 receptor antagonists - Low-Osmolar Contrasts

Hematologic Complications Thrombocytopenia - HIT – 1 - HIT – 2 - GP II b /III a inhibitors Neutropenia -Ticlopidin TTP - Ticlopidin and Plavix

Peripheral Vascular Complication Local bleeding & hematoma Retro peritoneal hemorrhage Pseudo-Aneurysm A-V fistula Thrombotic occlusion Arterial perforation Dissection

Coronary Complications Coronary artery spasm Dissection and Acute Closure No-Reflow and Slow-Flow Phenomena Coronary artery perforation Emergent CABG for failed PCI Restenosis ?

Coronary Artery Spasm -1 Balloon Angioplasty : 1- intra-lesional spasm 2- distal epicardial spasm 3- micro-vascular spasm 4- post procedural spasm Non-Balloon Devices Pathophysiology Managements

Coronary Artery Spasm Management Nitrates Removal of interventional hardware Calcium Antagonists Repeat balloon dilatation Systemic circulatory support Stents Rule out Dissection and Thrombus

Dissection & Acute Closure -1 Classification : - Acute closure - Imminent closure - Threatened closure Incidence & Timing of Acute closure Causes of Acute closure Risk factors for Acute closure Prevention of Acute closure Management of Acute closure

Types of Coronary artery Dissection

Dissection & Acute Closure -2 Causes of Acute closure : 1- dissection* 2- elastic recoil 3- spasm 4- thrombus % of probability of Acute closure.Classification of dissection ( * ): type A ( 0%), type B ( 3%), type C ( 10%), type D ( 30%), type E ( 9%), type F ( 69%). ( * ) : % of probability of Acute closure.

Coronary Artery Dissection

Coronary artery Dissection

Coronary Artery Thrombosis

Dissection & Acute Closure -3 Risk factors for Acute closure : - female,- DM,- MI,- UA,- age, …. - bend > 45,- long lesions,- tandem lesions - thrombus,- eccentric lesions,- calcified.., - residual stenosis > 35%,- prolonged post PTCA heparin,….. Prevention : 1- anti-platelet agents 2- anticoagulants 3- PTCA technique

Dissection & Acute Closure -4 Management : 1- Initial management. 2- Poor results after repeat PTCA. a- vessels > 2.5 mm b- vessels < 2.5 mm 3- Refractory Acute closure. 4- In-hospital management after successful reversal of Acute closure.

No-Reflow Phenomena -1 Definition Etiology Incidence Clinical manifestations Management

No-Reflow Phenomena -2 Management 1- reverse superimposed spasm 2- exclude coronary dissection 3- apply intra-coronary Ca 2+ blockers 4- GP II b /III a inhibitors 5- treat distal embolization 6- clear micro vascular plugging 7- increased coronary perfusion pressure 8- CABG 9- triage to ICU 10- others

Coronary Artery Perforation -1 Incidence and Classification Mechanisms and Risk factors Outcome Prevention: - guide wire positioning - device sizing - other devices considerations Management

Coronary Artery perforation

Coronary Artery Perforation -2 Management : A- non-operative 1- prolonged balloon inflation 2- Stents 3- pericardiocentesis 4- embolization 5- reversal of anticoagulation 6- monitoring & close follow-up B- operative

Emergency CABG -1 Indications : a- Acute occlusion of a major coronary artery. b- Sub optimal angioplasty with refractory myocardial ischemia. c- Coronary artery perforation with tamponade d- Left main injury or occlusion. e- Retained intra-coronary foreign bodies.

Emergency CABG -2 Contraindications : a- Acute cerebral injury. b- Metastatic or untreated malignancy c- AIDS d- End-stage lung disease e- Inoperable diffuse CAD f- Multiple previous cardiac operations g- Irreversible LV failure h- Cardiogenic shock* and Age > 80 yrs

Restenosis ?!!

Coronary Artery Dissection